@@ 1 文献来源rnTetsuya M,Satoshi M,Yasushi Y,et al.Gefitinib versus Cisplatin plus Docetaxel in patients with nonsmall-cell lung cancer harbouring mutations of the epidermal growth factor receptor(WJTOG3405):An open label,randomised phase 3 trial[J].Lancet Oncol,2010,11(2):121-128.rn2证据水平rn2b.rn3背景rn·含铂双药方案是晚期非小细胞肺癌(nonsmall cell lung cancer,NSCLC)的一线标准治疗方案,但目前已达到治疗平台期.
展开▼
